Meddenovo Drug Design
AI-driven drug development
- B2B
- AI-native
About Meddenovo Drug Design
A company specializing in AI technology and molecular modeling for drug development, offering unique solutions for drug candidate optimization and custom computational services
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Lyon, Auvergne-Rhône-Alpes, France
- Founded
- 2023
- Revenue
- $4.4M – $34.4MTamtam estimate
- Website
- meddenovo.com
Meddenovo Drug Design at a glance
Meddenovo Drug Design is a B2B company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, France.
Meddenovo Drug Design was founded in 2023.
Meddenovo Drug Design has 1–10 employees.
Meddenovo Drug Design's revenue is $4.4M – $34.4M (Tamtam estimate).
Frequently asked questions about Meddenovo Drug Design
What is Meddenovo Drug Design's revenue?
Tamtam estimates Meddenovo Drug Design's annual revenue at $4.4M – $34.4M.
How many employees does Meddenovo Drug Design have?
Meddenovo Drug Design has 1–10 employees.
Where is Meddenovo Drug Design headquartered?
Meddenovo Drug Design is headquartered in Lyon, Auvergne-Rhône-Alpes, France.
Selling to companies like Meddenovo Drug Design?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies